PHZE_PSEFL
ID PHZE_PSEFL Reviewed; 637 AA.
AC Q51791;
DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1996, sequence version 1.
DT 03-AUG-2022, entry version 94.
DE RecName: Full=Anthranilate synthase, phenazine specific;
DE EC=4.1.3.27;
DE Includes:
DE RecName: Full=Glutamine amidotransferase;
GN Name=phzE;
OS Pseudomonas fluorescens.
OC Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC Pseudomonadaceae; Pseudomonas.
OX NCBI_TaxID=294;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=NRRL B-15132 / 2-79;
RX PubMed=9573209; DOI=10.1128/jb.180.9.2541-2548.1998;
RA Mavrodi D.V., Ksenzenko V.N., Bonsall R.F., Cook R.J., Boronin A.M.,
RA Thomashow L.S.;
RT "A seven-gene locus for synthesis of phenazine-1-carboxylic acid by
RT Pseudomonas fluorescens 2-79.";
RL J. Bacteriol. 180:2541-2548(1998).
CC -!- FUNCTION: Involved in the biosynthesis of the antibiotic, phenazine, a
CC nitrogen-containing heterocyclic molecule having important roles in
CC virulence, competition and biological control.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=chorismate + L-glutamine = anthranilate + H(+) + L-glutamate +
CC pyruvate; Xref=Rhea:RHEA:21732, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:16567, ChEBI:CHEBI:29748, ChEBI:CHEBI:29985,
CC ChEBI:CHEBI:58359; EC=4.1.3.27;
CC -!- PATHWAY: Antibiotic biosynthesis; phenazine biosynthesis.
CC -!- MISCELLANEOUS: Component I catalyzes the formation of anthranilate
CC using ammonia rather than glutamine, whereas component II provides
CC glutamine amidotransferase activity.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; L48616; AAC18904.1; -; Genomic_DNA.
DR RefSeq; WP_043050174.1; NZ_JXCQ01000041.1.
DR AlphaFoldDB; Q51791; -.
DR SMR; Q51791; -.
DR PRIDE; Q51791; -.
DR KEGG; ag:AAC18904; -.
DR BioCyc; MetaCyc:MON-13690; -.
DR UniPathway; UPA00099; -.
DR GO; GO:0004049; F:anthranilate synthase activity; IEA:UniProtKB-EC.
DR GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR GO; GO:0002047; P:phenazine biosynthetic process; IEA:UniProtKB-UniPathway.
DR CDD; cd01743; GATase1_Anthranilate_Synthase; 1.
DR Gene3D; 3.40.50.880; -; 1.
DR Gene3D; 3.60.120.10; -; 1.
DR InterPro; IPR005801; ADC_synthase.
DR InterPro; IPR019999; Anth_synth_I-like.
DR InterPro; IPR015890; Chorismate_C.
DR InterPro; IPR029062; Class_I_gatase-like.
DR InterPro; IPR017926; GATASE.
DR InterPro; IPR006221; TrpG/PapA_dom.
DR PANTHER; PTHR11236; PTHR11236; 1.
DR Pfam; PF00425; Chorismate_bind; 1.
DR Pfam; PF00117; GATase; 1.
DR SUPFAM; SSF52317; SSF52317; 1.
DR SUPFAM; SSF56322; SSF56322; 1.
DR PROSITE; PS51273; GATASE_TYPE_1; 1.
PE 4: Predicted;
KW Antibiotic biosynthesis; Glutamine amidotransferase; Lyase; Transferase;
KW Virulence.
FT CHAIN 1..637
FT /note="Anthranilate synthase, phenazine specific"
FT /id="PRO_0000056908"
FT DOMAIN 437..628
FT /note="Glutamine amidotransferase type-1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00605"
FT REGION 1..434
FT /note="Anthranilate synthase component I"
FT ACT_SITE 517
FT /note="For GATase activity"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00605"
FT ACT_SITE 602
FT /note="For GATase activity"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00605"
FT ACT_SITE 604
FT /note="For GATase activity"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00605"
SQ SEQUENCE 637 AA; 69873 MW; D65235CA6139E0FE CRC64;
MSQAAARLME RILQPVPEPF ALLYRPESSG PGLLNVLIGE MSQPQVLADI DLPAPSIGAP
RLDVLTLIPY CQIAERGFAA VDDQSPLLAM NITEQQTISI EQMLALLPNV PIQLNNERFD
LSDASYAEIV SQVIANEIGS GEGANFVIKR TFLAEISEYQ PASALSFFRH LLEREKGVYW
TFIIHTGSRT FVGASPERHI SVKDGLAVMN PISGTYRYPP AGPSLTEVMD FLADRKEADE
LYMVVDEELK MMARICEDGG HVLGPYLKEM THLAHTEYFI EGRTRRDVRE ILHETLFAPT
VTGSPLESAC RVIERYEPQG RAYYSGMAAL IGSDGKGGRS LDSAILIRTA DIDNCGQVRI
SVGSTIVRHS EPLTEAAESR AKAAGLIAAL KNQAASRFGD HLQVRAALAS RNAYVSDFWL
MNSQQRQQTQ SDFSGRQVLI VDAEDTFTSM IAKQLRALGL VVTVRSFSDE YSFDGYDLVI
MGPGPGNPSD VQLPKIDHLH VAIRSLLNQQ RPFLAVCLSH QVLSLCLGLE LQRKAIPNQG
VQKQIDLFGN AERVGFYNTF AARSSSDRLD IDGIGTVEIS RDSETGEVHA LRGPAFASMQ
FHAESLLTQE GPRIIADLLR HALIHTPVDS SVSAAGR